Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 12. Mai 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8908  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178156  
   
Clinicopathological characteristics and prognostic outcomes of bladder urothelial neoplasms in patients under 40 years of age: a multicenter retrospective study.
Virchows Arch
Baycelebi D, Icoz AT, Yildirim NA, Okur SN, Kabul S, Simsek GG, Seday SZ, Gunes B, Tasligedik A, Melemezoglu D, Koc Sahin S, Aksoy Khurami F, Cevik Kaya F, Coban G, Ordu M, Y, Sener E, Bolova Bicak T, Kiran MM, Sungu N, Tok B, Kokenek Unal TD, Colak A, Hakkoymaz ZR, Yazgan A, Altindag SD, Bahc, Gokalp Satici FE, Gumuskaya B, Arslan G, Yuyucu Karabulut Y, Kosemehmetoglu K, Yaprak Bayrak B, Akgul M.
PMID: 42118290 [PubMed - as supplied by publisher]


Secondary leukaemia after testicular germ cell tumour treatment: a systematic review and meta-analysis.
BJU Int
Mousa A, Amiri A, Kaushal S, Wilson E, Tan I, Hamilton RJ.
PMID: 42117759 [PubMed - as supplied by publisher]


Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trial.
BJU Int
Wei N, Phillips RM, Kwon E, Stish BJ, Ehman EC, Lucien F, O'Byrne J, Bobek O, Shi Q, Andrews JR, Boorjian SA, Park SS, Orme JJ, Sharma V.
PMID: 42117295 [PubMed - as supplied by publisher]


Integrative genomic and functional characterization of FAM3 family genes reveals their diagnostic and prognostic roles in kidney renal clear cell carcinoma.
Cytotechnology
Zhe W, Abbas M, Abdel-Maksoud MA, Almanaa TN, Almutair S, Alamri A, Aufy M, Al-Qahtani WH, Hameed Y.
PMID: 42117032 [PubMed]


Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study.
Int J Urol
Shimoda H, Nakamura Y, Inoue M, Yoshinaga A, Kawamura N, Yonese I, Izumi K, Yamamoto T, Uehara S, Suzuki K, Toide M, Takazawa R, Araki S, Fukushima H, Fukuda S, Yuma W, Tanaka H, Yoshida S, Fujii Y.
PMID: 42116671 [PubMed - indexed for MEDLINE]


A Systematic Review on the Impact of Stigma, Anxiety, Depression on Quality of Life Among Prostate Cancer Patients.
Psychooncology
Rahim MABA, Ismail MB, Noor ABYA.
PMID: 42115779 [PubMed - indexed for MEDLINE]


Deep learning-based automatic field of view planning for prostate MRI in oblique coronal and oblique axial planes.
Sci Rep
Quinsten AS, Wetter A, Raczkowski M, Trembecki , Guz T, Oliveira S, Buchkremer R, Matusiewicz D, Nassenstein K, Forsting M, Demircio.
PMID: 42115680 [PubMed - indexed for MEDLINE]


Dissecting self-supervised learning strategies for transfer learning in MRI prostate cancer diagnosis.
Sci Rep
Facuse J, Campanini D, Parra D, Besa C, Salas R, Estévez PA, Mery D.
PMID: 42115652 [PubMed - as supplied by publisher]


Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial.
World J Urol
Zhang X, Wu Z, Hao L, Qiu X, Xu L, Zhang S, Guo H, Zhuang J.
PMID: 42115448 [PubMed - indexed for MEDLINE]


The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer.
Oncogene
Cheng B, Gong L, Xu H, Wang Z, Huang H, Guan X, Wu P.
PMID: 42115408 [PubMed - as supplied by publisher]


The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution.
Virchows Arch
Munari E, Antonini P, Cima L, Polati R, Caliò A, Gobbo STM, Colecchia M, Netto GJ, Antonelli A, Bertolo RG, Grisi C, Litjens G, Brunelli M.
PMID: 42115324 [PubMed - as supplied by publisher]


Androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer: Molecular mechanisms and therapeutic strategies.
Urol Oncol
Li J, Wang X, Tang X.
PMID: 42115122 [PubMed - as supplied by publisher]


Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer.
Eur Urol Focus
De Laere B, Crippa A, Discacciati A, Mortezavi A, Müller C, Røder A, Rannikko A, Ost P, Eklund M, Lindberg J, Grönberg H, ProBio Investigators.
PMID: 42115047 [PubMed - as supplied by publisher]


Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer.
J Immunother Cancer
Aggarwal R, Zhang J, Monk P, Zhu X, Jones R, Linch M, Costin D, de Bono J, Karsh LI, Petrylak DP, Zhang L, Deshpande R, Borderies P, Huang J, O'Neill V, Donkor M, Tagawa S.
PMID: 42114950 [PubMed - indexed for MEDLINE]


Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort.
Radiother Oncol
Guricová KM, van Houdt PJ, Salamanca MF, Schoots IG, Agrotis G, Draulans C, Haustermans K, Smeenk RJ, Kunze-Busch M, de Boer HCJ, van der Voort van Zyp JRN, Pos FJ, van der Heide UA.
PMID: 42114601 [PubMed - as supplied by publisher]


Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.
JCO Precis Oncol
Armstrong AJ, Saad F, Oya M, Shore N, Procopio G, Arslan C, Mehra N, Brown E, Joung JY, Sugimoto M, Özgüro, Gedye C, Sartor O, Poehlein C, Qiu P, Liu YZ, Li X, Harrington EA, McGuinness D, Kang J, Barnicle A, Clarke N.
PMID: 42114035 [PubMed - indexed for MEDLINE]


Fundamentals of bladder cancer nursing: from diagnosis pathways to holistic care.
Br J Nurs
Chatterton K.
PMID: 42113730 [PubMed - indexed for MEDLINE]


Holistic nursing care for men with testicular cancer from diagnosis to survivorship.
Br J Nurs
Hill B.
PMID: 42113725 [PubMed - indexed for MEDLINE]


Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.
JAMA Intern Med
Bhasin S, Burnett AL, Gagliano-Jucá T, Storer TW, Reid KF, Shang YV, Privat F, Chandra MS, Weiss M, Memish-Beleva Y, Lam H, Kibel AS, Pencina KM.
PMID: 42113507 [PubMed - as supplied by publisher]


Molecular Drivers of Prostate Cancer Metastasis: Emerging Targets for Precision Therapy.
Technol Cancer Res Treat
Iweala EEJ, Nwokoro CP.
PMID: 42112707 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 178156    Seite 1 von 8908  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1